aTYR PHARMA INC (ATYR) stock
ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.08−0.91 (-18.24%)
Close on Nov 18, 2026Market cap $400.20MP/E –Yield –
aTYR PHARMA market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
aTYR PHARMA's market cap was $16.60M on Nov 11, 2026, against $76.48M a year earlier. Over the last 5 years it ranged from $743.01K to $499.65M, with a median of $96.20M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.60M | +765.4% |
| 2025 | Dec 31, 2025 | $1.92M | -99.3% |
| 2024 | Dec 31, 2024 | $274.44M | +232.4% |
| 2023 | Dec 29, 2023 | $82.57M | +30.0% |
| 2022 | Dec 30, 2022 | $63.53M | -69.4% |
| 2021 | Dec 31, 2021 | $207.60M | +435.5% |
| 2020 | Dec 31, 2020 | $38.76M | +139.0% |
| 2019 | Dec 31, 2019 | $16.22M | +8.6% |
| 2018 | Dec 31, 2018 | $14.93M | -85.6% |
| 2017 | Dec 29, 2017 | $104.00M | +104.0% |
| 2016 | Dec 30, 2016 | $50.99M | -78.1% |
| 2015 | Dec 31, 2015 | $232.37M | – |
See a number that looks wrong?